120 related articles for article (PubMed ID: 37093849)
41. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
[TBL] [Abstract][Full Text] [Related]
42. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
43. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
45. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
46. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
Yang L; Li H; Huang A
Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
[TBL] [Abstract][Full Text] [Related]
47. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
48. miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
Jiang J; Liu Y; Zhao Y; Tian F; Wang G
Technol Cancer Res Treat; 2019; 18():1533033819852990. PubMed ID: 31138034
[TBL] [Abstract][Full Text] [Related]
49. Clinical Value of Circulating ZFAS1 and miR-590-3p in the Diagnosis and Prognosis of Chronic Heart Failure.
Chang G; Zhang W; Zhang M; Ding G
Cardiovasc Toxicol; 2021 Nov; 21(11):880-888. PubMed ID: 34319554
[TBL] [Abstract][Full Text] [Related]
50. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
51. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Springerplus; 2016; 5(1):1947. PubMed ID: 27917340
[TBL] [Abstract][Full Text] [Related]
52. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
[TBL] [Abstract][Full Text] [Related]
53. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
Hong Z; Zhang R; Qi H
Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
[TBL] [Abstract][Full Text] [Related]
55. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
56. Expression of miR-187 and miR-509-3p in serum of primary hepatocellular carcinoma patients and its evaluation of prognosis.
Dai G; Shen S; Liu Y; Ma X; Fang Y; Weng Y; Li C
J BUON; 2021; 26(4):1340-1345. PubMed ID: 34564990
[TBL] [Abstract][Full Text] [Related]
57. Deregulated microRNA-22-3p in patients with sepsis-induced acute kidney injury serves as a new biomarker to predict disease occurrence and 28-day survival outcomes.
Zhang H; Che L; Wang Y; Zhou H; Gong H; Man X; Zhao Q
Int Urol Nephrol; 2021 Oct; 53(10):2107-2116. PubMed ID: 33511504
[TBL] [Abstract][Full Text] [Related]
58. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
59. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
Sun B; Liu HF; Ding Y; Li Z
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
[TBL] [Abstract][Full Text] [Related]
60. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]